Inspire Medical Systems (INSP) Equity Average (2018 - 2026)

Inspire Medical Systems has disclosed Equity Average across 9 years of filings, most recently posting $786.8 million for Q1 2026.

• Equity Average for Q1 2026 came in at $786.8 million, up 18.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $786.8 million (up 18.72% YoY), and the FY2025 annual result was $735.4 million, up 16.53% from the prior year.
• Equity Average came in at $786.8 million for Q1 2026 at Inspire Medical Systems, up from $723.8 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $786.8 million in Q1 2026 to a low of $226.0 million in Q2 2022.
• The 5-year median for Equity Average is $580.8 million (2024), against an average of $556.1 million.
• Across the five-year window, Equity Average increased 0.27% in 2022 and soared 128.74% in 2023, its largest moves.
• Inspire Medical Systems' Equity Average stood at $483.1 million in 2022, then rose by 15.57% to $558.3 million in 2023, then rose by 24.14% to $693.1 million in 2024, then increased by 4.43% to $723.8 million in 2025, then advanced by 8.7% to $786.8 million in 2026.
• The last three Equity Average figures came in at $786.8 million (Q1 2026), $723.8 million (Q4 2025), and $672.1 million (Q3 2025), per Business Quant data.